Home > Healthcare > Medical Devices > Medical Supplies > anesthesia co2 absorbents market
Get a free sample of Anesthesia CO2 Absorbents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Anesthesia CO2 Absorbents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The anesthesia CO2 absorbents industry is consolidated in nature, with major companies competing to offer superior products in this business space. Prominent players such as Drägerwerk AG & Co. KGaA holds a significant share in the market. These companies are diligently directing their efforts towards continuous product innovation to gain substantial market share. For instance, Drägerwerk AG & Co. KGaA introduced the Drägersorb 800 HEPA, in order to offer more safe and effective anesthesia CO2 absorbents in the market.
Some of the eminent market participants operating in the anesthesia CO2 absorbents industry include:
Some of the major anesthesia CO2 absorbents companies are 3M, Baxter International, GE Healthcare, Cardinal Health, Beijing Kingst Commercial & Trade Co., Ltd., Ecolab Inc., Medline Industries, Inc., Philips Healthcare, Teleflex Incorporated, and Thermo Fisher Scientific.
U.S. anesthesia CO2 absorbents industry generated USD 20.9 million in revenue in 2022 and is estimated to expand at notable CAGR from 2023-2032 owing to higher technological advancements coupled with substantial healthcare expenditure in the region.
Anesthesia CO2 absorbents industry size from the medisorb segment generated USD 23.3 million in 2022 and is set to witness high demand through 2032 owing to rising application in surgeries to offer prolonged use capacity and cost-effectiveness.
Anesthesia CO2 absorbents industry was worth USD 74.1 million in revenue in 2022 and is projected to reach USD 121.9 million by 2032 driven by increasing usage in the surging number of surgical procedures globally.